Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care

Research output: Contribution to journal › Letter › Other › peer-review

Access to Document

@article{f95e4290d9364a01a2b895b3ec011d7c,

title = "Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care",

author = "Casan, {Joshua ML} and Alison Barraclough and Jake Shortt and Hawkes, {Eliza A.}",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/S2352-3026(19)30013-4",

language = "English",

volume = "6",

pages = "e119",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma

T2 - not yet the standard of care

AU - Casan, Joshua ML

AU - Barraclough, Alison

AU - Shortt, Jake

AU - Hawkes, Eliza A.

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85061927815&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(19)30013-4

DO - 10.1016/S2352-3026(19)30013-4

M3 - Letter

AN - SCOPUS:85061927815

VL - 6

SP - e119

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 3

ER -